Metformin treatment with or without mediterranean diet for the prevention of age-related diseases in people with metabolic syndrome: the MeMeMe randomized trial
Pasanisi P, Oliverio A, Baldassari I, et al.
Diabetes Care. 2024:dc241597.
Leggi
Breaking news
Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee
Diabetes Care. 2025;48(Supplement_1).
Leggi
SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and/or obesity: a systematic review and network meta-analysis
Bao Y, Hu Y, Shi M, Zhao Z
Diabetes Obes Metab. Pub. online 6 Dec 2024.
Leggi
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Moser O, Zaharieva DP, Adolfsson P, et al.
Diabetologia. Pub. online 10 Dec 2024.
Leggi
An exploratory analysis of glucagon-like peptide-1 (GLP-1) agonists and biosimilars: a literature review
Wen J, Razick A, How-Volkman C, et al.
Diabetes Obes Metab. Pub. online 9 Dec 2024.
Leggi
Glucocorticoid treatment and new-onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Golubic R, Mumbole H, Ismail MH, et al.
Diabet Med. 2024:e15475.
Leggi
Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes
Hua Z, Yang S, Li J, et al.
Diabetes Obes Metab. Pub. online 1 Dec 2024.
Leggi
The effect of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial
Virtanen JK, Hantunen S, Kallio N, et al.
Diabetologia. Pub. online 2 Dec 2024.
Leggi
Replacing dietary carbohydrate with protein and fat improves lipoprotein subclass profile and liver fat in type 2 diabetes independent of body weight: evidence from two randomized controlled trials
Thomsen MN, Skytte MJ, Samkani A, et al.
Am J Clin Nutr. 2024:S0002-9165(24)01425-4.
Leggi
The role of the glucagon-FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition
Moreno-Lopez M, Louvet I, Delalleau N, et al.
Diabetes Obes Metab. Pub. online 1 Dec 2024.
Leggi